Thienylindole azepines as serotonin 5-HT2C receptor ligands and uses thereof
申请人:ABT Holding Company
公开号:US09309262B2
公开(公告)日:2016-04-12
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).
[EN] THIENYLINDOLE AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF<br/>[FR] THIÉNYLINDOLE AZÉPINES UTILISÉES COMME LIGANDS DES RÉCEPTEURS DE SÉROTONINE 5-HT2C ET LEURS UTILISATIONS
申请人:ABT HOLDING CO
公开号:WO2014159067A1
公开(公告)日:2014-10-02
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).